190 related articles for article (PubMed ID: 37898402)
1. Molecular mechanism of EAG1 channel inhibition by imipramine binding to the PAS domain.
Wang ZJ; Ghorbani M; Chen X; Tiwari PB; Klauda JB; Brelidze TI
J Biol Chem; 2023 Dec; 299(12):105391. PubMed ID: 37898402
[TBL] [Abstract][Full Text] [Related]
2. Chlorpromazine binding to the PAS domains uncovers the effect of ligand modulation on EAG channel activity.
Wang ZJ; Soohoo SM; Tiwari PB; Piszczek G; Brelidze TI
J Biol Chem; 2020 Mar; 295(13):4114-4123. PubMed ID: 32047112
[TBL] [Abstract][Full Text] [Related]
3. The structural mechanism of KCNH-channel regulation by the eag domain.
Haitin Y; Carlson AE; Zagotta WN
Nature; 2013 Sep; 501(7467):444-8. PubMed ID: 23975098
[TBL] [Abstract][Full Text] [Related]
4. Identification of undecylenic acid as EAG channel inhibitor using surface plasmon resonance-based screen of KCNH channels.
Wang ZJ; Tiwari PB; Üren A; Brelidze TI
BMC Pharmacol Toxicol; 2019 Jul; 20(1):42. PubMed ID: 31315662
[TBL] [Abstract][Full Text] [Related]
5. Voltage-dependent activation in EAG channels follows a ligand-receptor rather than a mechanical-lever mechanism.
Malak OA; Gluhov GS; Grizel AV; Kudryashova KS; Sokolova OS; Loussouarn G
J Biol Chem; 2019 Apr; 294(16):6506-6521. PubMed ID: 30808709
[TBL] [Abstract][Full Text] [Related]
6. Calmodulin Regulates Human Ether à Go-Go 1 (hEAG1) Potassium Channels through Interactions of the Eag Domain with the Cyclic Nucleotide Binding Homology Domain.
Lörinczi E; Helliwell M; Finch A; Stansfeld PJ; Davies NW; Mahaut-Smith M; Muskett FW; Mitcheson JS
J Biol Chem; 2016 Aug; 291(34):17907-18. PubMed ID: 27325704
[TBL] [Abstract][Full Text] [Related]
7. Tuning of EAG K(+) channel inactivation: molecular determinants of amplification by mutations and a small molecule.
Garg V; Sachse FB; Sanguinetti MC
J Gen Physiol; 2012 Sep; 140(3):307-24. PubMed ID: 22930803
[TBL] [Abstract][Full Text] [Related]
8. Investigation of PAS and CNBH domain interactions in hERG channels and effects of long-QT syndrome-causing mutations with surface plasmon resonance.
Soohoo SM; Tiwari PB; Suzuki YJ; Brelidze TI
J Biol Chem; 2022 Jan; 298(1):101433. PubMed ID: 34801551
[TBL] [Abstract][Full Text] [Related]
9. Chlorpromazine inhibits EAG1 channels by altering the coupling between the PAS, CNBH and pore domains.
Ghorbani M; Wang ZJ; Chen X; Tiwari PB; Klauda JB; Brelidze TI
bioRxiv; 2024 Feb; ():. PubMed ID: 38464246
[TBL] [Abstract][Full Text] [Related]
10. Screening for Non-Pore-Binding Modulators of EAG K+ Channels.
Fernandes AS; Morais-Cabral JH; Harley CA
J Biomol Screen; 2016 Aug; 21(7):758-65. PubMed ID: 26975997
[TBL] [Abstract][Full Text] [Related]
11. Identifying regulators for EAG1 channels with a novel electrophysiology and tryptophan fluorescence based screen.
Brelidze TI; Carlson AE; Davies DR; Stewart LJ; Zagotta WN
PLoS One; 2010 Sep; 5(9):. PubMed ID: 20824064
[TBL] [Abstract][Full Text] [Related]
12. The Eag domain regulates the voltage-dependent inactivation of rat Eag1 K+ channels.
Lin TF; Jow GM; Fang HY; Fu SJ; Wu HH; Chiu MM; Jeng CJ
PLoS One; 2014; 9(10):e110423. PubMed ID: 25333352
[TBL] [Abstract][Full Text] [Related]
13. Effect of imipramine on ether à-go-go potassium channel (Kv1.10) expression in DU145 prostate cancer cells.
Söğüt F; Çömelekoğlu Ü; Dervişoğlu H; Eroğlu P; Yalin S; Yilmaz NŞ
Andrologia; 2022 Feb; 54(1):e14291. PubMed ID: 34729805
[TBL] [Abstract][Full Text] [Related]
14. The hERG potassium channel intrinsic ligand regulates N- and C-terminal interactions and channel closure.
Codding SJ; Trudeau MC
J Gen Physiol; 2019 Apr; 151(4):478-488. PubMed ID: 30425124
[TBL] [Abstract][Full Text] [Related]
15. Discovery of a heme-binding domain in a neuronal voltage-gated potassium channel.
Burton MJ; Cresser-Brown J; Thomas M; Portolano N; Basran J; Freeman SL; Kwon H; Bottrill AR; Llansola-Portoles MJ; Pascal AA; Jukes-Jones R; Chernova T; Schmid R; Davies NW; Storey NM; Dorlet P; Moody PCE; Mitcheson JS; Raven EL
J Biol Chem; 2020 Sep; 295(38):13277-13286. PubMed ID: 32723862
[TBL] [Abstract][Full Text] [Related]
16. Flavonoid regulation of EAG1 channels.
Carlson AE; Brelidze TI; Zagotta WN
J Gen Physiol; 2013 Mar; 141(3):347-58. PubMed ID: 23440277
[TBL] [Abstract][Full Text] [Related]
17. Mechanism of block of hEag1 K+ channels by imipramine and astemizole.
García-Ferreiro RE; Kerschensteiner D; Major F; Monje F; Stühmer W; Pardo LA
J Gen Physiol; 2004 Oct; 124(4):301-17. PubMed ID: 15365094
[TBL] [Abstract][Full Text] [Related]
18. Rescue of aberrant gating by a genetically encoded PAS (Per-Arnt-Sim) domain in several long QT syndrome mutant human ether-á-go-go-related gene potassium channels.
Gianulis EC; Trudeau MC
J Biol Chem; 2011 Jun; 286(25):22160-9. PubMed ID: 21536673
[TBL] [Abstract][Full Text] [Related]
19. Mechanistic insight into human ether-à-go-go-related gene (hERG) K+ channel deactivation gating from the solution structure of the EAG domain.
Muskett FW; Thouta S; Thomson SJ; Bowen A; Stansfeld PJ; Mitcheson JS
J Biol Chem; 2011 Feb; 286(8):6184-91. PubMed ID: 21135103
[TBL] [Abstract][Full Text] [Related]
20. hERG potassium channel gating is mediated by N- and C-terminal region interactions.
Gustina AS; Trudeau MC
J Gen Physiol; 2011 Mar; 137(3):315-25. PubMed ID: 21357734
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
